Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Orticumab in Participants With Prior Myocardial Infarction Who Have Elevated Coronary Inflammation Based on FAI Score Assessed by CCTA

NCT06927739 is registered in ClinicalTrials.gov with Abcentra as lead sponsor.

NCT NCT06927739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06927739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Orticumab in Participants With Prior Myocardial Infarction Who Have Elevated Coronary Inflammation Based on FAI Score Assessed by CCTA
Lead sponsor
Abcentra
Phase
Phase 2
Overall status
Recruiting
Start date
August 11, 2025
Completion date
June 1, 2027
Enrollment
240 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, atherosclerotic coronary vascular disease, coronary arterial disease (cad), heart disease, inflammation, myocardial infarct